AbbVie As Patent Enemy: Suit vs. MedImmune Aims To Halt Humira Royalty

18 Apr 2016

• By Brenda Sandburg

Latest legal battle over Humira centers around validity of patent covered in 1995 license agreement between predecessor firms.

More from United States

More from North America